WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Pfizer

PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.

www.pfizer.com

Filters
List of articles in category Pfizer
Title Published Date
Pfizer Commended For Leadership In Addressing Climate Change 22 September 2010
Pfizer to Acquire FoldRx Pharmaceuticals 02 September 2010
World Health Organization Grants Prequalification to Prevenar 13 24 August 2010
Pfizer Reports Second-Quarter 2010 Results 11 August 2010
Pfizer to Offer Free Public Access to Mental Health Assessment Tools 23 July 2010
Pfizer Strengthens Manufacturing Capabilities in Asia 13 July 2010
Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program 25 June 2010
Phase 3 Study Showed MACUGENĀ® Improved Vision Over Standard of Care 07 June 2010
Pfizer Global Manufacturing Announces Plans to Reconfigure its Global Plant Network 20 May 2010
World Bank and Pfizer Announce Initiative to Help Improve Healthcare Delivery 26 April 2010
Pfizer Discontinues Phase 3 Trial of SutentĀ® in Advanced Hepatocellular Carcinoma 23 April 2010
Stemgent and Pfizer Announce Collaboration 16 April 2010
Pfizer Posts Details About Interactions With U.S. Physicians 01 April 2010
Pfizer Signs Long-Term Agreement to Supply Prevenar 13 to The World's Poorest Countries 24 March 2010
Pfizer Discontinues A Phase 3 Study Of Figitumumab 12 March 2010
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon 04 March 2010
Pfizer's Prevnar 13 Recommended by CDC's Advisory Committee On Immunization Practices 25 February 2010
Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc. 24 February 2010
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness 09 February 2010
Pfizer Reports Fourth-Quarter and Full-Year 2009 Results 04 February 2010
  • Start
  • Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next
  • End

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
  • Research identifies, exploits vulnerability in certain high-risk cancers
  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Pfizer

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.